US 6,191,117 B1Granted

Methods of producing weight loss and treatment of obesity

OwnerWalter E. Kozachukinventor

Life of this patent

Estimating the term…

Abstract

Methods are disclosed for the acute and chronic treatment of obesity using drugs whose mechanism includes the interaction and antagonism of the kainate/AMPA receptor. Methods are disclosed for employing the drug topiramate (topomax) as monotherapy or in combination therapy with lamotrigene, valproic acid, valproic acid and carbamezepine combination, or felbamate (felbatol).

Claims7

Dependent claims

A method for treating a human suffering from obesity, comprising the steps of:

administering to the human a compound whose mechanism of action includes antagonism of the kainite and/or AMPA receptor.

Dependencies are inferred from the claim text.

Facts

Application: 09/613,692Filed 10 Jul 2000
Granted: 20 Feb 2001
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/70
Medicinal preparations containing organic active ingredients: carbohydrates; Sugars; Derivatives thereof
A61K 31/19
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids: carboxylic acids, e.g. valproic acid
A61K 31/22
Of carboxylic acids: of acyclic acids, e.g. pravastatin
A61K 31/55
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having seven-membered rings, e.g. azelastine, pentylenetetrazole

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results